Type II variation for application COFEPRIS-2021-0014. Type II variation: Labeling Change for Semaglutidex — critical change

Variation Number
COFEPRIS-2021-0014-V114
Type
Type II
Status
Overdue
Fee
€18,947
Submitted
2023-01-31
Approved
—
Description

Type II variation: Labeling Change for Semaglutidex — critical change